TCR1188-ABC Cells in KRAS-mutated Cancers

NCT07594067 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma
Colorectal Cancer
Non-Small Cell Lung Cancer
Pancreatic Adenocarcinoma

Interventions

BIOLOGICAL: TCR1188-ABC cells
DRUG: Fludarabine + Cyclophosphamide combination
DRUG: Tocilizumab

Sponsor

University of Pennsylvania

Collaborators

[object Object]